• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBioVersys AG
    Picture of BioVersys AG logo

    BIOV — BioVersys AG Share News

    CH₣27.000.000.00%
    ch flag iconLast trade - 00:00
    HealthcareSpeculativeSmall Cap
    • Market Cap
      CH₣158.07m
    • Enterprise Value
      CH₣179.80m
    • Revenue
      CH₣0.80m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BIOV Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BIOV Dividends
    • Brief: Bioversys Expects Total Operating Loss Of CHF 40-45 Mln For FY2026

      18/03/2026 07:40
    • RCS - Bio Versys AG - BioVersys and partners’

      19/02/2026 07:02
    • Brief: BioVersys Announces BV100 Phase 3 Initiation And Provides Business Update

      11/12/2025 11:58
    • Brief: Bioversys Says Patent Claims For Its BV100 Drug Candidate Have Been Granted In China

      31/03/2025 06:05
    • UBS, Stifel start coverage of BioVersys with 'buy;' shares climb

      20/03/2025 14:03
    • UBS starts coverage of BioVersys with 'buy;' shares climb

      20/03/2025 09:56
    • Brief: BioVersys Announces Partial Exercise Of Over-Allotment Option

      10/03/2025 06:07
    • Swiss biotech Bioversys' shares open slightly higher on stock market debut

      07/02/2025 08:22

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.